Supportive Care | Specialty

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Good News for Cancer Survivorship

March 25th 2013

The number of cancer survivors in the US continues to rise.

Treating Complex Cancer Pain-Looking Outside the Box

March 19th 2013

When treating complex cancer pain cases, clinicians should "look outside the box" and consider new agents, as well as new uses and administration routes for older agents.

Managing NETs in the Community Setting

March 14th 2013

Treating Neuroendocrine Tumors With Chemotherapy

March 14th 2013

Targeted Therapies in Neuroendocrine Tumors

March 14th 2013

Emerging Treatment Options in Neuroendocrine Tumors

March 14th 2013

Role of Somatostatin Analogs in Neuroendocrine Tumors

March 14th 2013

Surgical Treatment of Neuroendocrine Tumors

March 14th 2013

The Genetics Behind Familial Neuroendocrine Tumors

March 14th 2013

Techniques for Diagnosing Neuroendocrine Tumors

March 14th 2013

Challenges in the Diagnosis of Neuroendocrine Tumors

March 14th 2013

The Role of Biomarkers in Neuroendocrine Tumors

March 14th 2013

Histological Classification of Neuroendocrine Tumors

March 14th 2013

Neuroendocrine Tumors: Introduction and Overview

March 14th 2013

Side Effects With Regorafenib Occur Early and Tend to Taper

March 8th 2013

The incidence of adverse effects with regorafenib in metastatic colorectal cancer is highest during the first treatment cycle and then diminishes over time.

Preparing Nurses for Advanced Practice in Oncology and Palliative Care

March 5th 2013

Barbara Daly, PhD, RN, FAAN, and Helen Foley, MSN, AOCNS®, offer highlights of their institution's oncology and palliative care program, which successfully prepares graduates to assume advanced practice roles in these important areas.

To Die or Not to Die, That Is the Question

February 11th 2013

It has always been our job as cancer care physicians to guide the patient, even when our guidance is not what one would like to hear.

Dr. Grothey on the Time Course of Regorafenib-Associated AEs

January 28th 2013

Axel Grothey, MD, from the Mayo Clinic, Rochester, Minnesota, discusses the time course of adverse events following treatment with regorafenib, as observed in the CORRECT study.

Improving Survivorship

January 8th 2013

ASCO issues recommendations for improving cancer survivorship care.

Navigating Patients' Chemotherapy Decision Making

December 20th 2012

Patients considering chemotherapy treatment need to understand the risks and benefits of treatment in order to make an informed decision to undergo-or forgo-treatment.